Halper Sadeh investigates six proposed corporate transactions

Sep 25, 2026 11:38 (30d ago)

Halper Sadeh is investigating six proposed sales or mergers for potential securities-law violations and breaches of shareholder fiduciary duties.
The proposed consideration includes $127 per Integer share, $33.50 per Beazer share, 1.5401 Indivior shares per Supernus share and $61.20 per LXP share; Fulcrum shareholders are expected to own 5.0% and TriCo shareholders approximately 35% of their respective combined companies.
The firm said deal terms may limit superior offers and may seek higher consideration, additional disclosures, information or other shareholder benefits.

Halper Sadeh LLC said it is investigating six proposed corporate transactions for potential violations of federal securities laws and breaches of fiduciary duties, or legal obligations to shareholders. The matters involve Integer Holdings’ sale to KKR for $127 per share; Beazer Homes’ sale to Dream Finders Homes for $33.50 in cash per share; Supernus Pharmaceuticals’ sale to Indivior Pharmaceuticals for 1.5401 Indivior common shares per Supernus share; Fulcrum Therapeutics’ merger with Slate Medicines; TriCo Bancshares’ sale to First Hawaiian for 2.095 First Hawaiian shares per TriCo share; and LXP Industrial Trust’s sale to Brookfield Asset Management and Canada Pension Plan Investment Board for $61.20 per share in cash. Halper Sadeh said the transactions may include terms limiting superior competing offers and that insiders may receive financial benefits unavailable to ordinary shareholders. The firm may seek increased consideration, additional disclosures and information, or other relief and benefits, and is inviting shareholders to discuss their rights and options at no cost or obligation. The firm said matters would be handled on a contingent-fee basis, with shareholders not responsible for its out-of-pocket legal fees or expenses.